Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Journal of Gerontology
|
September 1, 1988
Physical activity and fracture risk in a free-living elderly cohort
G S Sorock, T L Bush, A L Golden, et al.
Preventive Medicine
|
March 1, 1988
Benefits and risks of menopausal estrogen and/or progestin hormone use
V L Ernster, T L Bush, G R Huggins, et al.
Cancer Research
|
January 15, 1996
In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor
J M Piepmeier, N Rabidou, S C Schold, et al.
Cancer Detection and Prevention
|
January 1, 1994
A prospective study of endogenous hormones and breast cancer
K J Helzlsouer, A J Alberg, T L Bush, et al.
JAMA
|
March 3, 1993
Prospective study of serum CA-125 levels as markers of ovarian cancer
K J Helzlsouer, T L Bush, A J Alberg, et al.
Controlled Clinical Trials
|
August 1, 1995
Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, T L Bush, I Mebane-Sims, et al.
American Journal of Epidemiology
|
September 11, 2001
Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation
Y Liu, J Ding, T L Bush, et al.
The Journal of Biological Chemistry
|
January 5, 1990
Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase
A J Bitonti, J A Dumont, T L Bush, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1994
Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial
R Marcus, G Greendale, B A Blunt, et al.
Anticancer Research
|
September 1, 1996
Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma
A J Bitonti, R J Baumann, T L Bush, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Journal of Gerontology
|
September 1, 1988
Physical activity and fracture risk in a free-living elderly cohort
G S Sorock, T L Bush, A L Golden, et al.
Preventive Medicine
|
March 1, 1988
Benefits and risks of menopausal estrogen and/or progestin hormone use
V L Ernster, T L Bush, G R Huggins, et al.
Cancer Research
|
January 15, 1996
In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor
J M Piepmeier, N Rabidou, S C Schold, et al.
Cancer Detection and Prevention
|
January 1, 1994
A prospective study of endogenous hormones and breast cancer
K J Helzlsouer, A J Alberg, T L Bush, et al.
JAMA
|
March 3, 1993
Prospective study of serum CA-125 levels as markers of ovarian cancer
K J Helzlsouer, T L Bush, A J Alberg, et al.
Controlled Clinical Trials
|
August 1, 1995
Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, T L Bush, I Mebane-Sims, et al.
American Journal of Epidemiology
|
September 11, 2001
Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation
Y Liu, J Ding, T L Bush, et al.
The Journal of Biological Chemistry
|
January 5, 1990
Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase
A J Bitonti, J A Dumont, T L Bush, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1994
Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial
R Marcus, G Greendale, B A Blunt, et al.
Anticancer Research
|
September 1, 1996
Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma
A J Bitonti, R J Baumann, T L Bush, et al.
Page
of 10